Search Results for: genome editing
Deals AcquisitionsVertex Pharmaceuticals
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Trials & Approvals CRISPR Genome Editing
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
IPO Initial Public OfferingIPOKymera TherapeuticsMetagenomi
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
Special biotech
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
Trials & Approvals CRISPR-CAS9
FDA Approves A CRISPR-Based Therapy for Sickle Cell Disease
2023-12-12
Interviews JapanCell and Gene Therapy
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Partnerships SanofiCRISPR
Sanofi Inks Two Major Strategic R&D Collaborations in a Single Week
2023-07-24
Special ASGCTCell and Gene Therapy
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
2023-06-02
R&D Genome Editing
Re-engineered Bacterial “Syringes” for Programmable Protein Delivery
2023-04-06
Interviews iPSC
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
Special mRNA
A New Phase in Drug Development: Programming the Genome
2023-03-02
Partnerships Gene Editing
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Partnerships RNA Editing
GSK Buys into Wave’s Oligonucleotide Program With $170 Million
2022-12-14
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Special Synthetic Biology
Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications
2022-10-20
1 2 3 … 10
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top